Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

In both univariate logistic regression analysis (OR: 2.46, 95% CI: 1.06 to 5.68; P = 0.036) and multivariate logistic regression analysis (OR: 2.54, 95% CI: 1.02 to 6.33; P = 0.046), the 25(OH)D3 < 20 ng/ml demonstrated to be a significant risk factor of primary endpoints for those hypertensive patients.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The participants were not included when there was a record of cardiac arrest, severe dyspnea, severe liver disease (including cirrhosis), renal failure (including dialysis), serious infection recently, and other granulomatous diseases.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Associations of vitamin D with coronary revascularization and heart rate variability in hypertensive patients

Study design awaiting verification · Frontiers in Cardiovascular Medicine · 2025

Original publication title

Associations of vitamin D with coronary revascularization and heart rate variability in hypertensive patients

Zongbin Li; Yuting Zou; Ruizhe Li; Minglei Zhang

© 2025 Li, Zou, Li and Zhang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Vitamin D deficiency was prevalent in hypertensive patients and was independently associated with the risk of coronary revascularization. Vitamin D deficiency also affects HRV and ARR values in hypertensive patients.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Even though substantial evidence has found that vitamin D deficiency correlates to risk factors for cardiovascular disease (CVD), few studies have shown how vitamin D affects coronary revascularization and heart rate variability (HRV). We aimed to explore the connection between vitamin D levels with coronary revascularization and HRV in hypertensive patients.

Source: Background

Abstract: What methods does the paper describe?

A total of the 250 eligible participants with hypertension hospitalized at the Department of Cardiology, Sixth Medical Center of Chinese PLA General Hospital was consecutively recruited. The status of vitamin D is measured utilizing serum 25-hydroxyvitamin D3 [25(OH)D3] concentrations. The primary endpoints were defined as patients undergoing coronary revascularization treatment. The secondary endpoints were defined as the variation in HRV. HRV indices were recorded in participants using a 24-h Holter electrocardiogram (ECG). In addition, direct renin concentrations and plasma aldosterone concentrations were measured in the supine and standing positions.

Source: Methods

Abstract: Results

In the study, 165 eligible patients assigned to the vitamin D deficiency [25(OH)D3 < 20 ng/ml] group and 85 to the vitamin D non-deficiency[25(OH)D3 ≥ 20 ng/ml] group. In both univariate logistic regression analysis (OR: 2.46, 95% CI: 1.06 to 5.68; P = 0.036) and multivariate logistic regression analysis (OR: 2.54, 95% CI: 1.02 to 6.33; P = 0.046), the 25(OH)D3 < 20 ng/ml demonstrated to be a significant risk factor of primary endpoints for those hypertensive patients. Receiver operating characteristic curve (ROC) analysis showed the multivariable-adjusted model for predicting primary endpoints in patients with hypertension, with an area under the curve (AUC) of 0.73 (95% CI: 0.64 to 0.82, p < 0.001).

Regarding secondary endpoints, the HRV indexes such as standard deviation of normal-to-normal (NN) intervals (SDNN) (P = 0.04), standard deviation of the averages of NN intervals in all 5-min segments (SDANN) (P = 0.03), and Triangle indexes values (P = 0.02) were significantly different in the two groups. Finally, we observed that hypertensive patients with vitamin D deficiency had significantly greater aldosterone and aldosterone-to-renin ratio (ARR) values than those having vitamin D non-deficiency.

Source: Results

Abstract: Conclusion

Vitamin D deficiency was prevalent in hypertensive patients and was independently associated with the risk of coronary revascularization. Vitamin D deficiency also affects HRV and ARR values in hypertensive patients.

Source: Conclusion
Authors’ abstract

Background

Even though substantial evidence has found that vitamin D deficiency correlates to risk factors for cardiovascular disease (CVD), few studies have shown how vitamin D affects coronary revascularization and heart rate variability (HRV). We aimed to explore the connection between vitamin D levels with coronary revascularization and HRV in hypertensive patients.

Methods

A total of the 250 eligible participants with hypertension hospitalized at the Department of Cardiology, Sixth Medical Center of Chinese PLA General Hospital was consecutively recruited. The status of vitamin D is measured utilizing serum 25-hydroxyvitamin D3 [25(OH)D3] concentrations. The primary endpoints were defined as patients undergoing coronary revascularization treatment. The secondary endpoints were defined as the variation in HRV. HRV indices were recorded in participants using a 24-h Holter electrocardiogram (ECG). In addition, direct renin concentrations and plasma aldosterone concentrations were measured in the supine and standing positions.

Results

In the study, 165 eligible patients assigned to the vitamin D deficiency [25(OH)D3 < 20 ng/ml] group and 85 to the vitamin D non-deficiency[25(OH)D3 ≥ 20 ng/ml] group. In both univariate logistic regression analysis (OR: 2.46, 95% CI: 1.06 to 5.68; P = 0.036) and multivariate logistic regression analysis (OR: 2.54, 95% CI: 1.02 to 6.33; P = 0.046), the 25(OH)D3 < 20 ng/ml demonstrated to be a significant risk factor of primary endpoints for those hypertensive patients. Receiver operating characteristic curve (ROC) analysis showed the multivariable-adjusted model for predicting primary endpoints in patients with hypertension, with an area under the curve (AUC) of 0.73 (95% CI: 0.64 to 0.82, p < 0.001).

Regarding secondary endpoints, the HRV indexes such as standard deviation of normal-to-normal (NN) intervals (SDNN) (P = 0.04), standard deviation of the averages of NN intervals in all 5-min segments (SDANN) (P = 0.03), and Triangle indexes values (P = 0.02) were significantly different in the two groups. Finally, we observed that hypertensive patients with vitamin D deficiency had significantly greater aldosterone and aldosterone-to-renin ratio (ARR) values than those having vitamin D non-deficiency.

Conclusion

Vitamin D deficiency was prevalent in hypertensive patients and was independently associated with the risk of coronary revascularization. Vitamin D deficiency also affects HRV and ARR values in hypertensive patients.

Publication and source details

Original title: Associations of vitamin D with coronary revascularization and heart rate variability in hypertensive patients

Zongbin Li; Yuting Zou; Ruizhe Li; Minglei Zhang

Frontiers in Cardiovascular Medicine · 2025

Edited by: Jelena Milešević, University of Belgrade, Serbia

Reviewed by: William B. Grant, Sunlight Nutrition and Health Research Center, United States

Dolina Gencheva, Plovdiv Medical University, Bulgaria

* Correspondence: Zongbin Li lizongbin@301hospital.com.cn
†

These authors have contributed equally to this work and share first authorship

© 2025 Li, Zou, Li and Zhang.2025Li, Zou, Li and Zhanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Capital's Funds for Health Improvement and ResearchCSH2022-1G-5071Hygiene and Health Development Scientific Research Fostering Plan of Haidian District of BeijingHP-2021-03-80602The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by grants from Capital's Funds for Health Improvement and Research (CSH2022-1G-5071) and the Hygiene and Health Development Scientific Research Fostering Plan of Haidian District of Beijing (HP-2021-03-80602).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:06:21.748165+00:00

DOI: 10.3389/fcvm.2025.1590701 · PMC12491254